Differences in lung physiology and immune function in children may lie behind their decreased rates of symptomatic infections, hospitalization and death, according to a study from The University of Texas and Baylor College of Medicine (both TX, USA).
Browsing: Research > Clinical
Researchers have identified a specific change in the SARS-CoV-2 coronavirus spike protein that may increase its transmission, making it more infectious in cell culture.
Harvard’s Wyss Institute is leveraging its unique technology innovation capabilities to develop diagnostic, therapeutic, and vaccine interventions for COVID-19 at lightning speed.
Researchers have accurately profiled the immune response to COVID-19 in critically ill patients, allowing them to identify six inflammatory molecules as potential targets for COVID-19 treatment.
In this interview we speak to José Javier García from Pivotal about his company´s involvement in a large-scale clinical trial testing the safety and efficacy of hyperimmune convalescent plasma treatment in COVID-19 patients.
Researchers at the Emory Vaccine Center have demonstrated that a novel adjuvant, 3M-052, can aid long-lasting immunity against HIV in rhesus monkeys. This could have implications for developing successful vaccines against HIV, influenza and COVID-19.
Rebiotix (MN, USA) recently announced positive preliminary results from an ongoing clinical trial investigating the use of an investigational microbiota-based formulation, RBX2660, for the reduction of C. diff infection.
Dexamethasone, a steroid drug typically used to treat inflammation in conditions such as arthritis and asthma, has recently been tested as part of the Recovery trial at Oxford University (UK), and results are looking positive.
A recent analysis of COVID-19 cases suggests that up to 45% of SARS-CoV-2 infections may be asymptomatic. This highlights the need for expansive testing and contact tracing to quash the pandemic.